Aldosterone mediates glomerular inflammation in experimental mesangial proliferative glomerulonephri

Journal of Nephrology

Volumn 26, Issue 1, 2013, Pages 199-206

  Qin, Danping ^a,b   Morita, Hiroyuki ^a,c   Inui, Kiyoko ^a   Tayama, Hironori ^a   Inoue, Yoshihiko ^a   Yoshimura, Ashio ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^b GUANGZHOU RED CROSS HOSPITAL   (China)

^c AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Animal models; Glomerular disease; Inflammation

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALDOSTERONE; ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; CREATININE; CYCLINE; ED 1 PROTEIN; EPLERENONE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITROGEN; POTASSIUM; SPIRONOLACTONE; UNCLASSIFIED DRUG; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SELECTIVITY; GLOMERULAR INFILTRATION; GLOMERULOPATHY; MACROPHAGE MIGRATION INHIBITION; MALE; MESANGIUM CELL; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; POTASSIUM BLOOD LEVEL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; RENAL PROTECTION; UPREGULATION; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION;

ACTINS; ALDOSTERONE; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CCL2; CREATININE; DEOXYGUANOSINE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; ISOANTIBODIES; MACROPHAGES; MALE; MESANGIAL CELLS; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PROTEINURIA; RATS; RATS, WISTAR; SPIRONOLACTONE;

EID: 84877098081     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000125     Document Type: Article

References (30)

1. Johnson RJ. The glomerular response to injury: progression or resolution? Kidney Int. 1994;45(6):1769-1782.
2. Epstein M. Aldosterone blockade: an emerging strategy for abrogating progressive renal disease. Am J Med. 2006; 119(11):912-919.
3. Hollenberg NK. Aldosterone in the development and progression of renal injury. Kidney Int. 2004;66(1):1-9.
4. Nishiyama A, Yoshizumi M, Hitomi H, et al. The SOD mimetic tempol ameliorates glomerular injury and reduces mitogenactivated protein kinase activity in Dahl salt-sensitive rats. J Am Soc Nephrol. 2004;15(2):306-315.
5. Zia AA, Kamalov G, Newman KP, et al. From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation. Hypertens Res. 2010;33(11):1091-1101.
6. Nishiyama A, Yao L, Fan Y, et al. Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability. Hypertension. 2005;45(4): 710-716.
7. Nagai Y, Miyata K, Sun GP, et al. Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts. Hypertension. 2005;46(4):1039-1045.
8. Gullulu M, Akdag I, Kahvecioglu S, Filiz G, Savci V. Aldosterone blockage in proliferative glomerulonephritis prevents not only fibrosis, but proliferation as well. Ren Fail. 2006; 28(6):509-514.
9. Asai M, Monkawa T, Marumo T, et al. Spironolactone in combination with cilazapril ameliorates proteinuria and renal interstitial fibrosis in rats with anti-Thy-1 irreversible nephritis. Hypertens Res. 2004;27(12):971-978.
10. Johnson RJ, Iida H, Alpers CE, et al. Expression of smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest. 1991;87:847-858.
11. Yoshimura A, Iwasaki S, Inui K, et al. Endothelin-1 and endothelin B type receptor are induced in mesangial proliferative nephritis in the rat. Kidney Int. 1995;48(4):1290-1297.
12. Yoshimura A, Gordon K, Alpers CE, et al. Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int. 1991;40(3): 470-476.
13. Iida H, Seifert R, Alpers CE, et al. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci USA. 1991;88(15):6560-6564.
14. Johnson RJ, Garcia RL, Pritzl P, Alpers CE. Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol. 1990;136(2):369-374.
15. Chen YM, Chien CT, Hu-Tsai MI, et al. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis. Kidney Int. 1999;56(3):932-943.
16. Jefferson JA, Johnson RJ. Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model). J Nephrol. 1999;12(5):297-307.
17. Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE; AHA Council on High Blood Pressure Research, Professional and Public Education Subcommittee. Recommendations for blood pressure measurement in animals: summary of an AHA scientific statement from the Council on High Blood Pressure Research, Professional and Public Education Subcommittee. Arterioscler Thromb Vasc Biol. 2005;25:478-479.
18. Quan ZY, Walser M, Hill GS. Adrenalectomy ameliorates ablative nephropathy in the rat independently of corticosterone maintenance level. Kidney Int. 1992;41(2):326-333.
19. Horiuchi M, Nishiyama H, Hama J, et al. Characterization of renal aldosterone receptors in genetically hypertensive rats. Am J Physiol. 1993;264:F286-F291.
20. Greene EL, Kren S, Hostetter TH. Role of aldosterone in the remnant kidney model in the rat. J Clin Invest. 1996;98(4): 1063-1068.
21. Rocha R, Chander PN, Khhanna K et al. Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension. 1998;31:451-458.
22. Rocha R, Stier CT Jr, Kifor I, et al. Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology. 2000;141(10):3871-3878.
23. Blasi ER, Rocha R, Rudolph AE, Blomme EA, Polly ML, McMahon EG. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int. 2003;63(5):1791-1800.
24. Chen YM, Hu-Tsai MI, Lin SL, Tsai TJ, Hsieh BS. Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy 1 glomerulonephritis in rats. Nephrol Dial Transplant. 2003;18(12):2505-2514.
25. Panzer U, Thaiss F, Zahner G, et al. Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis. Kidney Int. 2001;59:1762-1769.
26. Schneider A, Panzer U, Zahner G, et al. Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-beta. Kidney Int. 1999;56:135-144.
27. Schneider A, Harendza S, Zahner G, et al. Cyclooxygenase metabolites mediate glomerular monocyte chemoattractant protein-1 formation and monocyte recruitment in experimental glomerulonephritis. Kidney Int. 1999; 55:430-441.
28. Han SY, Kim CH, Kim HS, et al. Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats. J Am Soc Nephrol. 2006;17:1362-1372.
29. Shigenaga MK, Gimeno CJ, Ames BN. Urinary 8-hydroxy-22-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA. 1989;86(24):9697-9701.
30. Nagase M, Fujita T. Aldosterone and glomerular podocyte injury. Clin Exp Nephrol. 2008;12(4):233-242.